LPIXEL
Sales partnership with iSurgery to spread medical AI
~Starting provision of “Medical Image Analysis Software Chest Bone Indicator” through the medical AI platform “EIRL AI Partner Program”~ ……
[Image 1: https://prtimes.jp/i/10005/65/resize/d10005-65-3f0cc7b505b82e749fef-0.png&s3=10005-65-3fc2562c37f45d397410011b0a423bb0-3900×555.png] L-Pixel Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Tomihisa Kamata, hereinafter referred to as “L-Pixel”) is a startup company that develops and sells AI medical devices in the orthopedic field, iSurgery Co., Ltd. (Headquarters: Tokyo, Japan) We are pleased to announce that we have started a sales partnership with Chuo Ward, Representative Director and Physician: Yoichi Sato (hereinafter referred to as “iSurgery”) as the first partner since the establishment of the medical AI platform “EIRL AI Partner Program.” Going forward, we will accelerate collaboration between the two companies over the medium to long term and contribute to the spread of medical AI.
Background to the sales partnership and the future that will be realized In order to easily improve bone health, iSurgery provides the “Medical Image Analysis Software Chest Bone Indicator” (1), an AI solution that utilizes chest X-ray images. In addition, L-Pixel provides solutions for various modalities including chest X-ray images using AI image diagnosis support technology “EIRL” that supports doctors’ diagnosis. The two companies have entered into a sales collaboration to reduce the burden on medical institutions and expand the possibilities of chest X-ray images. For this sales partnership, we are utilizing the framework of the “EIRL AI Partner Program,” which began service in January 2024. (Reference URL:
https://lpixel.net/news/press-release/2024/11002/)
The collaboration between iSurgery and L-Pixel is expected to significantly improve the use of chest X-ray images and bring about ground-breaking changes in the medical industry that will contribute to the early detection of diseases. By combining iSurgery’s bone analysis technology and L-Pixel’s image diagnostic technology, this collaboration will help solve the problem of doctor shortages and medical disparities and improve the quality of medical care. This collaboration, which aims to spread Japan’s medical AI technology to the world and open up a new path for the evolution and expansion of medical services, will begin with a sales partnership in Japan, and then expand its knowledge overseas to help address the needs of an aging society. We also aim to address health issues.
[Image 2: https://prtimes.jp/i/10005/65/resize/d10005-65-ff42900d5a117cc9817e-1.jpg&s3=10005-65-4db3b1421605402fd1d49f520559cd26-807×538.jpg] Details of sales partnership
The “Chest Bone Indicator” provided by iSurgery can be used via the EIRL platform provided by Lpixel. By allowing medical institutions to use iSurgery and L-Pixel services on the same platform, they can enhance their services to patients without requiring additional work or time. This will allow patients and patients attending medical institutions to receive a wide range of evaluations and tests without having to visit other medical institutions or undergo additional tests.
・On-premises
By installing an EIRL server within a medical institution and linking it with an existing PACS (medical image management system), you can check the results of AI-based analysis of chest X-ray images. In this sales partnership, we will install a “Chest Bone Indicator” server alongside the EIRL server. This allows bone analysis to be performed via the EIRL server, allowing medical institutions to enhance their AI analysis services while reducing PACS connection costs and on-site burdens.
[Image 3: https://prtimes.jp/i/10005/65/resize/d10005-65-e440ace8c9d30ac4436f-2.png&s3=10005-65-5ac15319f66b6ef458a90dd9ba921916-3900×1644.png ]
・Cloud (preparing to provide service)
In an online connection environment, you can check the AI analysis results by uploading chest X-ray images without the need for new equipment installation or system coordination. In this sales partnership, the analysis software for “Chest Bone Indicator” will be operated on EIRL Cloud. This allows bone analysis to be performed on the EIRL Cloud platform, making it possible for medical institutions to use multiple services from a single viewer.
[Image 4: https://prtimes.jp/i/10005/65/resize/d10005-65-57792217471581c6ee9c-3.png&s3=10005-65-ba1eff2967bfaa7b9be8a9237d24c8a8-3900×1473.png ]
Comments from representatives of both companies
L-Pixel Co., Ltd. Representative Director Tomihisa Kamata
Deterioration of bone condition is difficult to see, and by the time it is noticed, it is often already connected to serious problems. In order to solve this problem, we strongly hope that bone evaluation using the “Chest Bone Indicator” will become popular as a part of health checkups. Additionally, through our sales partnership, we hope to address the health issues of Japan’s aging population and spread our knowledge both domestically and internationally. We hope that through this collaboration, the scope of medical AI will further expand.
iSurgery Co., Ltd. Representative Director Yoichi Sato
We are very happy about the collaboration with L-Pixel. Through collaboration with the company, which is a top runner in medical AI and has a highly complete product lineup, we will strive to further improve our services. iSurgery and Lpixel’s customer targets have a complementary relationship. Through this collaboration, we will be able to provide services to patients who attend medical institutions that cannot be covered by each other, and we hope that this will ultimately contribute to the equalization of medical care.
(1) Brand name: Medical image analysis software Chest Bone Indicator Certification number: 305ADBZX00032000
Company Profile
[About iSurgery Co., Ltd.]
With the vision of “early detection and treatment of osteoporosis patients to reduce the number of fractures and the need for nursing care, and to extend healthy lifespans,” we provide solutions that evaluate bone conditions from chest X-ray images. Aiming for a future where anyone, anywhere can easily undergo an osteoporosis evaluation, we aim to make a breakthrough in solving long-standing issues faced by an aging society through digital transformation (DX) of osteoporosis treatment. .
[About L-Pixel Co., Ltd.]
L-Pixel Co., Ltd. has strengths in image analysis in the life science field, and has developed high-precision software by applying image analysis technology, especially artificial intelligence technology, in the medical, pharmaceutical, and agricultural fields. . We are developing our business centered on “EIRL”, an AI image diagnosis support technology that supports doctors’ diagnosis, and “IMACEL”, an image analysis AI specialized for drug discovery.
More details about this release:
https://prtimes.jp/main/html/rd/p/000000065.000010005.html